While BPC-157 excels at local tissue repair and angiogenesis, TB-500 provides superior systemic inflammation reduction and promotes cell migration to injury sites through different mechanisms
Retatrutide Retatrutide is designed as a once-weekly injectable triple hormone receptor agonist that activates the receptors for: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon This triple-receptor action aims to improve appetite regulation, glucose control, and energy expenditure potentially leading to greater metabolic effects than earlier drugs targeting only one or two pathways
Diabetes 61 , 888896 (2012)
At NovaSyn Labs, every semaglutide batch is verified through third-party HPLC and LC-MS testing and supplied with a Certificate of Analysis (COA)
Together, GLP-1 and Sermorelin provide a comprehensive approach to weight management: GLP-1 targets appetite and blood sugar, while Sermorelin strengthens the body, preserves muscle, and supports long-term health